myeloproliferative disease
AMP Report Recommends Genes for Chronic Myeloid Neoplasm Sequencing Panels
The working group reviewed data to identify a minimum of 34 commonly mutated genes that should be included in pan-myeloid targeted panels.
Qiagen JAK2 Test Gets FDA Clearance for Additional Blood Cancer Types
The US Food and Drug Administration cleared Qiagen's Ipsogen JAK2 RGQ PCR Kit for additional use in the diagnosis of all myeloproliferative neoplasms
Qiagen Gets FDA Clearance for JAK2 Assay to Help Diagnose Blood Cancer Type
The test runs on Qiagen's Rotor-Gene Q MDx system and is designed to qualitatively detect the JAK2 V617F/G1849T allele in genomic DNA from whole blood.